Cargando…

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes

BACKGROUND: Extensive research has increased our understanding of the molecular alterations needed for non-small cell lung cancer (NSCLC) development. Deregulation of a pathway including MYCN, HMGA2 and CDKN2A, with the participation of DICER1, is of importance in several solid tumours, and may also...

Descripción completa

Detalles Bibliográficos
Autores principales: Eide, Hanne A., Halvorsen, Ann Rita, Bjaanæs, Maria Moksnes, Piri, Hossein, Holm, Ruth, Solberg, Steinar, Jørgensen, Lars, Brustugun, Odd Terje, Kiserud, Cecilie Essholt, Helland, Åslaug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746877/
https://www.ncbi.nlm.nih.gov/pubmed/26858029
http://dx.doi.org/10.1186/s12885-016-2104-9
_version_ 1782414884275748864
author Eide, Hanne A.
Halvorsen, Ann Rita
Bjaanæs, Maria Moksnes
Piri, Hossein
Holm, Ruth
Solberg, Steinar
Jørgensen, Lars
Brustugun, Odd Terje
Kiserud, Cecilie Essholt
Helland, Åslaug
author_facet Eide, Hanne A.
Halvorsen, Ann Rita
Bjaanæs, Maria Moksnes
Piri, Hossein
Holm, Ruth
Solberg, Steinar
Jørgensen, Lars
Brustugun, Odd Terje
Kiserud, Cecilie Essholt
Helland, Åslaug
author_sort Eide, Hanne A.
collection PubMed
description BACKGROUND: Extensive research has increased our understanding of the molecular alterations needed for non-small cell lung cancer (NSCLC) development. Deregulation of a pathway including MYCN, HMGA2 and CDKN2A, with the participation of DICER1, is of importance in several solid tumours, and may also be of significance in the pathogenesis of NSCLC. METHODS: Gene expression of MYCN, HMGA2, CDKN2A and DICER1 were investigated with RT-qPCR in surgically resected NSCLC tumour tissue from 175 patients. Expression of the let-7 microRNA family was performed in 78 adenocarcinomas and 16 matching normal lung tissue samples using microarrays. The protein levels of HMGA2 were determined by immunohistochemistry in 156 tumour samples and the protein expression was correlated with gene expression. Associations between clinical data, including time to recurrence, and expression of mRNA, protein and microRNAs were analysed. RESULTS: Compared to adenocarcinomas, squamous cell carcinomas had a median 5-fold increase in mRNA expression of HMGA2 (p = 0.003). A positive correlation (r = 0.513, p < 0.010) between HMGA2 mRNA expression and HMGA2 protein expression was seen. At the protein level, 90 % of the squamous cell carcinomas expressed high levels of the HMGA2 protein compared to 47 % of the adenocarcinomas (p < 0.0001). MYCN was positively correlated with HMGA2 (p < 0.010) and DICER1 mRNA expression (p < 0.010), and the expression of the let-7 microRNAs seemed to be correlated with the genes studied. MYCN expression was associated with time to recurrence in multivariate survival analyses (p = 0.020). CONCLUSIONS: A significant difference in HMGA2 mRNA expression between the histological subtypes of NSCLC was seen with a higher expression in the squamous cell carcinomas. This was also found at the protein level, and we found a good correlation between the mRNA and the protein expression of HMGA2. Moreover, the expression of MYCN, HMGA2, and DICER1 seems to be correlated to each other and the expression of the let7-genes impacted by their expression. MYCN gene expression seems to be of importance in time to recurrence in this patient cohort with resected NSCLC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2104-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4746877
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47468772016-02-10 The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes Eide, Hanne A. Halvorsen, Ann Rita Bjaanæs, Maria Moksnes Piri, Hossein Holm, Ruth Solberg, Steinar Jørgensen, Lars Brustugun, Odd Terje Kiserud, Cecilie Essholt Helland, Åslaug BMC Cancer Research Article BACKGROUND: Extensive research has increased our understanding of the molecular alterations needed for non-small cell lung cancer (NSCLC) development. Deregulation of a pathway including MYCN, HMGA2 and CDKN2A, with the participation of DICER1, is of importance in several solid tumours, and may also be of significance in the pathogenesis of NSCLC. METHODS: Gene expression of MYCN, HMGA2, CDKN2A and DICER1 were investigated with RT-qPCR in surgically resected NSCLC tumour tissue from 175 patients. Expression of the let-7 microRNA family was performed in 78 adenocarcinomas and 16 matching normal lung tissue samples using microarrays. The protein levels of HMGA2 were determined by immunohistochemistry in 156 tumour samples and the protein expression was correlated with gene expression. Associations between clinical data, including time to recurrence, and expression of mRNA, protein and microRNAs were analysed. RESULTS: Compared to adenocarcinomas, squamous cell carcinomas had a median 5-fold increase in mRNA expression of HMGA2 (p = 0.003). A positive correlation (r = 0.513, p < 0.010) between HMGA2 mRNA expression and HMGA2 protein expression was seen. At the protein level, 90 % of the squamous cell carcinomas expressed high levels of the HMGA2 protein compared to 47 % of the adenocarcinomas (p < 0.0001). MYCN was positively correlated with HMGA2 (p < 0.010) and DICER1 mRNA expression (p < 0.010), and the expression of the let-7 microRNAs seemed to be correlated with the genes studied. MYCN expression was associated with time to recurrence in multivariate survival analyses (p = 0.020). CONCLUSIONS: A significant difference in HMGA2 mRNA expression between the histological subtypes of NSCLC was seen with a higher expression in the squamous cell carcinomas. This was also found at the protein level, and we found a good correlation between the mRNA and the protein expression of HMGA2. Moreover, the expression of MYCN, HMGA2, and DICER1 seems to be correlated to each other and the expression of the let7-genes impacted by their expression. MYCN gene expression seems to be of importance in time to recurrence in this patient cohort with resected NSCLC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2104-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-08 /pmc/articles/PMC4746877/ /pubmed/26858029 http://dx.doi.org/10.1186/s12885-016-2104-9 Text en © Eide et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Eide, Hanne A.
Halvorsen, Ann Rita
Bjaanæs, Maria Moksnes
Piri, Hossein
Holm, Ruth
Solberg, Steinar
Jørgensen, Lars
Brustugun, Odd Terje
Kiserud, Cecilie Essholt
Helland, Åslaug
The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes
title The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes
title_full The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes
title_fullStr The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes
title_full_unstemmed The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes
title_short The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes
title_sort mycn-hmga2-cdkn2a pathway in non-small cell lung carcinoma—differences in histological subtypes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746877/
https://www.ncbi.nlm.nih.gov/pubmed/26858029
http://dx.doi.org/10.1186/s12885-016-2104-9
work_keys_str_mv AT eidehannea themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT halvorsenannrita themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT bjaanæsmariamoksnes themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT pirihossein themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT holmruth themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT solbergsteinar themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT jørgensenlars themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT brustugunoddterje themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT kiserudcecilieessholt themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT hellandaslaug themycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT eidehannea mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT halvorsenannrita mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT bjaanæsmariamoksnes mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT pirihossein mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT holmruth mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT solbergsteinar mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT jørgensenlars mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT brustugunoddterje mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT kiserudcecilieessholt mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes
AT hellandaslaug mycnhmga2cdkn2apathwayinnonsmallcelllungcarcinomadifferencesinhistologicalsubtypes